Interobserver variation in interpretation of serial liver biopsies from patients with chronic hepatitis C

Journal of Viral Hepatitis

Volumn 9, Issue 6, 2002, Pages 443-449

  Gronbaek K ^a   Christensen, P B ^b   Hamilton Dutoit, S ^c   Federspiel, B H ^d   Hage, E ^a   Jensen, O J ^d   Vyberg, M ^e  

^a Rigshospitalet   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Chronic hepatitis C; Histopathology; Interobserver variation

Indexed keywords

ALPHA INTERFERON;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NECROSIS; PRIORITY JOURNAL; REPRODUCIBILITY; SCORING SYSTEM; STATISTICAL ANALYSIS;

ANTIVIRAL AGENTS; BIOPSY; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION; INTERFERON ALFA-2B; INTERFERON-ALPHA; LIVER; LIVER CIRRHOSIS; NECROSIS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 18744397193     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2002.00389.x     Document Type: Article

References (21)

1. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240-243.
2. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832.
3. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969-974.
4. Esteban JI, Lopez-Talavera JC, Genesca J et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Int Med 1991; 115: 443-449.
5. Merican I, Sherlock S, McIntyre N, Dusheiko GM. Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Quarterly Journal of Medicine 1993; 86: 119-125.
6. National Institutes of Health Consensus Development Conference Panel Statement: Management of Hepatitis C. Hepatology 1997; 26 (Suppl 1): 2S-10S.
7. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond. Hepatology 2000; 31: 241-246.
8. De Groote J, Desmet VJ, Gedigk P et al. A classification of chronic hepatitis. Lancet 1968; 2: 626-628.
9. Bianchi L, De Groote J, Desmet VJ et al. Acute and chronic hepatitis revisited. Review by an International Group. Lancet 1977; 2: 914-919.
10. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
11. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 1991; 13: 372-374.
12. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
13. Bedossa P, Poynard T and the METAVIR cooperative study group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-293.
14. The French METAVIR cooperative study group. Interobserver and intraobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
15. Goldin RD, Goldin JG, Burt AD et al. Intra-observer and interobserver variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 1996; 25: 649-654.
16. Westin J, Lagging LM, Wejstål R, Norkrans G, Dhillon AP. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999; 19: 183-187.
17. Farrell GC, Bacon BR, Goldin RD and the clinical advisory group for the hepatitis C comparative study. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial. Hepatology 1998; 27: 1121-1127.
18. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd Edn. New York: Wiley & Sons, 1981.
19. Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
20. Gjorup T. The kappa coefficient and the prevalence of a diagnosis. Methods Inf Med 1988; 27: 184-186
21. Kramer MS, Feinstein AR. Clinical biostatistics, the biostatistics of concordance. Clin Pharmacol Ther 1981; 29: 111-123